Biologic agents for the treatment of rheumatoid arthritis

Rheumatic Disease Clinics of North America

Volumn 22, Issue 1, 1996, Pages 117-132

  Strand, V ^a   Keystone, E ^a   Breedveld, F ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIBODY CONJUGATE; CD4 ANTIGEN; CD5 ANTIGEN; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

B LYMPHOCYTE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INFLAMMATORY CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 0029922235     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70265-9     Document Type: Article

References (56)

1. J. Abrams CTLA4 Ig phase Ia clinical trial in psoriasis. Presented at the Biologic Agents in Autoimmune Diseases IV Conference March 1995 Arthritis Foundation Atlanta
2. W.P. Arend R.G. Joslin R.C. Thompson An IL-1 inhibitor from human monocytes: Production and characterization of biologic properties J Immunol 142 1989 1851
3. W.P. Arend Interleukin-1 receptor antagonist: A new member of the interleukin family J Clin Invest 88 1991 1445
4. W.P. Arend J.-M. Dayer Inhibition of the production and effects of IL-1 and TNFα in RA Arthritis Rheum 38 1995 151
5. G. Bandara G.M. Mueller J. Galea-Lauri Intra-articular expression of biologically active interleukin-1 receptor antagonist protein by ex vivo gene transfer Proc Natl Acad Sci USA 90 1993 10704
6. B.M. Cronstein G. Weissman The adhesion molecules of inflammation Arthritis Rheum 36 1993 147
7. J.J. Cush P.E. Lipsky Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis Arthritis Rheum 31 1988 1230
8. J.J. Cush N.J. Olsen R.H. Brooks Cyclic anti-CD5 immunoconjugate therapy in early rheumatoid arthritis Arthritis Rheum 36 1993 S130
9. J.C. Delafuente B.H. Resman-Targoff Monoclonal antibodies in the treatment of rheumatoid arthritis Ann Pharmacother 28 1994 650
10. B. Drevlow R. Lovis Phase 1 study of recombinant human Interleukin-1 receptor (RHU IL-1R) administered subcutaneously in patients with active rheumatoid arthritis Arthritis Rheum 37 1994 S339
11. B. Drevlow J. Capezio R. Lovis Phase 1 study of recombinant human interleukin-1 receptor (RHU-IL-1R) administered intra-articularly in active rheumatoid arthritis Arthritis Rheum 36 1993 S39
12. M.J. Elliot R.N. Maini M. Feldmann Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis Lancet 344 1994 1105
13. M.J. Elliot R.N. Maini M. Feldmann Repeated therapy with monoclonal antibody to tumor necrosis factor α (cA2) in patients with rheumatoid arthritis Lancet 344 1994 1127
14. T.J. Evans D. Moyes A. Carpenter Protective effect of 55- but not 75-kd soluble tumor necrosis factor receptor-immunoglobulin fusion proteins in an animal model of gram-negative sepsis J Exp Med 180 1994 2173
15. R. Fernandez-Botran Soluble cytokine receptors: Their role in immunoregulation FASEB J 5 1991 2567
16. A. Gaur C.G. Fathman Immunotherapeutic strategies directed at the trimolecular complex Adv Immunol 56 1994 219
17. D. Goldberg P. Morel L. Chatenoud Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients J Autoimmune 4 1991 617 630
18. B. Hepburn Chimeric anti-TNFαmAb in rheumatoid arthritis. Presented at the Biologic Agents in Autoimmune Disease IV Conference March 1995 Arthritis Foundation Atlanta
19. J. Holoshitz A. Matitiau I.R. Cohen Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II J Clin Invest 73 1984 211
20. G. Horneff G. Burmester F. Emmrich Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody Arthritis Rheum 34 1991 129
21. G. Horneff U. Sack J.R. Kalden Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment: Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis Clin Exp Immunol 91 1993 207
22. M.D. Howell J.P. Divelfy K.A. Lundean Limited T cell receptor b chain heterogeneity among interleukin-2 receptor positive synovial T cells suggests a role for superantigen in rheumatoid arthritis Proc Natl Acad Sci USA 88 1991 10921
23. J.D. Isaacs V.K. Manna B.L. Hazleman CAMPATH 1H in RA: A study of multiple IV dosing Arthritis Rheum 36 1993 S40
24. J. Johnston W. Spreen Treatment of rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H. Strand V. Simon L. S. Pillemer Biologic Agents In Autoimmune Diseases III 1994 Arthritis Foundation 55
25. J. Karsh J.H. Klippel P.H. Plotz Lymphopheresis in rheumatoid arthritis: A randomized trial Arthritis Rheum 24 1981 867
26. A.F. Kavanaugh L.S. Davis L.A. Nichols Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule-1 (ICAM-1) Arthritis Rheum 37 1994 992
27. L. Klareskog U. Forsum A. Scheynius Evidence in support of a self perpetuating HLA-DR dependent delayed type cell reaction in RA Med Sciences 79 1982 3632
28. J.M. Laar van A.M.M. Miltenburg M.J.A. Verdonk T cell receptor B chain gene rearrangements of T cell populations expanded from multiple sites of synovial tissue obtained from a patient with RA Scand J Immunol 35 1992 187
29. M.E. Lebsack C.C. Paul J.J. Martindale A dose and regimen ranging study of IL-1 receptor antagonist in patients with rheumatoid arthritis Arthritis Rheum 36 1993 S39
30. L.W. Moreland P. Pratt M. Mayes Minimal efficacy of a depleting chimeric anti-CD4 (CM-T412) in treatment of patients with refractory rheumatoid arthritis (RA) receiving concomitant methotrexate (MTX) Arthritis Rheum 36 1993 S39
31. L.W. Moreland K.L. Sewell W.F. Sullivan Double-blind placebo-controlled phase II trial of diphtheria interleukin-2 fusion toxin (DAB 486 IL-2) in patients with refractory rheumatoid arthritis Arthritis Rheum 36 1993 S39
32. L.W. Moreland I.W. Heck Jr W.J. Koopman Vβ17 T cell receptor peptide vaccine: Results of a phase 1 dose-finding study in patients with rheumatoid arthritis Arthritis Rheum 37 1994 S337
33. L.W. Moreland G.R. Margolies I.W. Heck Soluble tumor necrosis factor receptor (sTNFR): Results of a phase I dose-escalation study in patients with rheumatoid arthritis Arthritis Rheum 37 1994 S295
34. L.W. Moreland P.W. Pratt R.P. Bucy Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody: Long-term follow-up of CD4+ T cell counts Arthritis Rheum 37 1994 834
35. X. Paliard S.G. West J.A. Lafferty Evidence for the effects of a superantigen in RA Science 253 1992 325
36. G.S. Panayi J.S. Lanchbury G.W. Kingsley The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis Arthritis Rheum 35 1992 729
37. H.E. Paulus H.I. Machleder S. Levine Lymphocyte involvement in rheumatoid arthritis: Studies during thoracic duct drainage Arthritis Rheum 20 1977 1249
38. H.E. Paulus M.J. Egger J.R. Ward An analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs based on the findings in patients treated with placebo Arthritis Rheum 33 1990 447
39. E.C.C. Rankin E.H.S. Choy D. Kassumos A double-blind, placebo-controlled ascending dose trial of the recombinant humanized anti-TNFα antibody CDP 571 in patients with rheumatoid arthritis Arthritis Rheum 37 1994 S295
40. C. Reiter B. Kakavand E.P. Rieber Treatment of rheumatoid arthritis with monoclonal CD4 antibody MT-151 Arthritis Rheum 34 1991 525
41. P.C.M. Res C.G. Schaar F.C. Breedveld Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis Lancet 478 1988
42. E.M. Ruderman M.E. Weinblatt L.M. Thurmond Synovial tissue response to treatment with CAMPATH 1H Arthritis Rheum 37 1994 S240
43. R.H. Schwartz Costimulation of T lymphocytes: The role of CD28, CTLA-4 and B7/ BB1 in interleukin production and immunotherapy Cell 71 1992 1065
44. K.L. Sewell L.W. Moreland J.J. Cush Phase I/II double blind dose response trial of a second fusion toxin, DAB 389 IL-2 in rheumatoid arthritis Arthritis Rheum 36 1993 S130
45. A.M. Solinger D.E. Yocum J. Tesser Clinical activity in an early phase I trial of primatized IDEC-CE 9.1 Arthritis Rheum 37 1994 S337
46. V. Strand P.E. Lipsky G.W. Cannon Effects of administration of an anti-CD5 immunoconjugate in rheumatoid arthritis Arthritis Rheum 36 1993 620
47. V. Strand E.C. Keystone Biologic interventions in rheumatoid arthritis: I J Biotech Healthcare 1 1995 283
48. V. Strand E.C. Keystone Biologic interventions in rheumatoid arthritis: II J Biotech Healthcare 1 1995 377
49. S. Strober A. Tanay E. Field Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis: A double-blind, randomized trial Ann Intern Med 102 1985 441
50. P.A. van der Lubbe B.A.C. Dijkmans H.M. Markusse Lack of clinical effect of CD4 monoclonal antibody therapy in early RA: A placebo-controlled trial Arthritis Rheum 38 1995 1097
51. Wacholtz MC: Humanized IgG4 anti CD4 monoclonal antibody in RA. In Strand V, Simon L, Pillemer S (eds): Biologic Agents in Autoimmune Diseases IV. Arthritis Foundation, in press
52. Weinblatt ME: The experience with CAMPATH 1H. Presented at the Biologic Agents in Autoimmune Diseases IV Conference. Atlanta, Arthritis Foundation, in press
53. M.E. Weinblatt J. Coblyn A. Maier Continued lymphocyte suppression following single dose mAb therapy with CAMPATH 1 H: A 20 month follow up Arthritis Rheum 37 1994 S420
54. D. Wendling E. Racadot B. Morel-Fourrier Treatment of rheumatoid arthritis with anti CD4 monoclonal antibody: Open study of 25 patients with the B-F5 clone Clin Rheumatol 11 1992 542
55. R.F. Winchester P.K. Gregersen The molecular basis of susceptibility to rheumatoid arthritis: The confirmational equivalence hypothesis Springer Semin Immunopathol 10 1988 119
56. Winklehake J: HLA DR4/1 peptide vaccine for RA. In Strand V, Simon L, Pillemer S (eds): Biologic Agents in Autoimmune Diseases IV. Arthritis Foundation, in press